Allergen, Individual-Grass pollen Bermuda Grass Durva (Cynodon Grass) G2

The Allergen, Individual-Grass pollen Bermuda Grass Durva (Cynodon Grass) G2 is a targeted home allergy test that detects specific IgE antibodies to Bermuda (Durva/Cynodon dactylon) grass pollen. The test uses a small blood sample collected at home and analysed by a certified laboratory to determine sensitisation to this common grass pollen, which is a frequent trigger of seasonal allergic rhinitis and asthma in the UAE.

This test is useful for confirming whether symptoms such as sneezing, itchy eyes, nasal congestion, or seasonal asthma are driven by Bermuda grass pollen so clinicians can tailor avoidance strategies, medication, or allergen immunotherapy. It is suitable for adults and children under clinical guidance, and is convenient for residents across Dubai and the UAE who prefer home sample collection and fast, lab-validated results.

• Specific IgE — Bermuda (Durva/Cynodon) grass pollen
• Specific IgE class/level (quantitative)
• Total IgE (where available)
• Result interpretation (Negative / Sensitised with class)

• Recurring seasonal nasal or eye allergy during grass pollen season
• Unexplained wheeze or worsening asthma correlated with outdoor exposure
• Before starting allergen-specific immunotherapy (desensitisation)
• When planning avoidance measures at home, school, or workplace in the UAE
• Persistent allergic symptoms despite empirical antihistamine treatment

• Definitive identification of sensitisation to Bermuda (Durva/Cynodon) grass pollen
• Supports personalised treatment: medication choice and immunotherapy decisions
• Convenient home sample collection with lab-based analysis across Dubai/UAE
• Reduces trial-and-error medication use and improves symptom management
• Provides clear data for occupational or educational accommodation plans

• At-home capillary blood collection (finger-prick) or arranged venous draw if required
• No fasting required prior to sample collection
• Inform the lab/clinician of recent allergen immunotherapy or systemic immunosuppressants
• Adult consent required; testing children should be arranged with paediatric guidance